Company Active LTD

Company profile

Odyssey Therapeutics UK Limited

ERROR: The requested URL could not be retrieved

Odyssey Therapeutics UK Limited is a UK company with status active founded in 2018 based in East Midlands.

CRN
11609778
Founded
2018
Age
7

Overview

Legal name
ODYSSEY THERAPEUTICS UK LIMITED
Region
East Midlands
Registered address
3 WEEKLEY WOOD CLOSE
KETTERING
NORTHAMPTONSHIRE
UNITED KINGDOM
NN14 1UQ
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Odyssey Therapeutics UK Limited
CRN 11609778
2
Direct and ultimate controller
N/A
CRN N/A

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

14 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

27 Sep
2024

Accounts With Accounts Type Small

Accounts Analysed

AA | Transaction MzQzNzU0MjM5OWFkaXF6a2N4

Published 27 Sep 2024 02:31

08 Oct
2018

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2020
Funded years
2020
Age at first award
1 years

Projects

2020 CR&D Bilateral

Quantum technology – mapping and map integration for buried assets (QT-MIBA)

1 Jul 2020 to 31 Mar 2022

Awarded
£83,462
Total cost £119,231

Quantum technology -- mapping and map integration for buried assets (QT-MIBA) seeks to evaluate the feasibility of obtaining and publishing more complete and accurate information on the location of buried assets through enhanced processing of geophysical sensor data. The goal of QT-MIBA is to address the accidental strikes on underground utility pipes and...

2020 CR&D Bilateral Lead participant

QUANTIFI - QUANTum computIng For heterogeneous catalytIc materials solutions.

1 Apr 2020 to 31 Dec 2021

Awarded
£129,618
Total cost £185,168

QUANTIFI aims to develop a world-leading Quantum Computing Dynamical Mean Field Theory (DMFT) solution for strongly correlated catalytic materials. DMFT is needed to properly describe a large number of important transition metal oxides used as catalytic materials for emissions reductions as well as oxides for batteries and other applications. On conventio...

Product types

CR&D Bilateral